Hans Lassmann

MS & MOGAD: differences in response to immunomodulatory therapies 2:01
MS & MOGAD: differences in response to immunomodulatory therapies
Hans Lassmann • 27 Oct 2022
The pathology of MS and MOGAD: similarities and differences 1:49
The pathology of MS and MOGAD: similarities and differences
Hans Lassmann • 27 Oct 2022
The immune mechanisms behind neurodegeneration in progressive MS 2:55
The immune mechanisms behind neurodegeneration in progressive MS
Hans Lassmann • 27 Oct 2022
The role of Epstein-Barr virus in the pathogenesis of MS 2:03
The role of Epstein-Barr virus in the pathogenesis of MS
Hans Lassmann • 27 Oct 2022
Austria’s historical contribution to neurology 1:24
Austria’s historical contribution to neurology
Hans Lassmann • 27 Jun 2022
Updates on inflammatory demyelinating diseases 2:20
Updates on inflammatory demyelinating diseases
Hans Lassmann • 27 Jun 2022
The inflammatory process in MS 2:14
The inflammatory process in MS
Hans Lassmann • 27 Jun 2022
Pathology of multiple sclerosis: unanswered questions 1:22
Pathology of multiple sclerosis: unanswered questions
Hans Lassmann • 27 Jun 2022
The contribution of neuropathology to multiple sclerosis research 1:09
The contribution of neuropathology to multiple sclerosis research
Hans Lassmann • 27 Jun 2022
The role of oxidative stress in MS lesions 1:53
The role of oxidative stress in MS lesions
Hans Lassmann • 27 Jun 2022
Therapy relevant pathomechanisms in neuroimmunology 1:41
Therapy relevant pathomechanisms in neuroimmunology
Hans Lassmann • 27 Jun 2022
The content of VJNeurology is intended for healthcare professionals